Wealth Enhancement Advisory Services’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
Other funds holding IONS
Wealth Enhancement Advisory Services's IONS Position: Q3 2026 in Review
Wealth Enhancement Advisory Services increased its Ionis Pharmaceuticals (IONS) stake by 12% in Q3 2026, buying an estimated $37.7K and bringing the position to 6,058 shares worth $262K. The position accounts for ﹤0.01% of the portfolio, ranked #3487.
Wealth Enhancement Advisory Services first reported a position in IONS in Q2 2024 and has held it in 7 quarters since. The position peaked at $673K in Q4 2025. 465 funds tracked by Wall St. Rank hold IONS as of Q3 2026.
- Wealth Enhancement Advisory Services held 6,058 shares of Ionis Pharmaceuticals worth $262K as of Q3 2026.
- Wealth Enhancement Advisory Services bought 664 Ionis Pharmaceuticals shares in Q3 2026, an estimated $37.7K.
- Ionis Pharmaceuticals made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q3 2026, its #3487 holding.
- Wealth Enhancement Advisory Services first reported a position in Ionis Pharmaceuticals in Q2 2024 and has held it in 7 quarters since.
- Wealth Enhancement Advisory Services's Ionis Pharmaceuticals position peaked at $673K in Q4 2025.
- 465 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.
Based on Wealth Enhancement Advisory Services's 13F filing for Q3 2026, filed 13 Oct 2026.